1C2T - Sequence, Chains, Asymmetric and Biological Units

• Title: NEW INSIGHTS INTO INHIBITOR DESIGN FROM THE CRYSTAL STRUCTUR STUDIES OF E. COLI GAR TRANSFORMYLASE IN COMPLEX WITH BETA- 10-FORMYL-5,8,10-TRIDEAZAFOLIC ACID.
• Keywords: PURINE BIOSYNTHESIS, ANTI-CANCER AGENT, INHIBITOR COMPLEX, TRANSFERASE
• Experiment: X-ray diffraction
• Number of Models: 1

Database	ID code	Status	Coordinate files
			Header	Asymmetric unit	Biological unit
PDB	1C2T	released	available	available	Quaternary Structure Server

Asymmetric unit from PDB

Unit	Type	Name	Chain ID	Residues	Atoms	Hetatoms
1	Protein	GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE	A	209	1617	0
2	Protein	GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE	B	209	1617	0
3	Ligand	GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE	A	2	0	53
4	Ligand	GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE	B	2	0	53
5	Water			197	0	197
total				619	3234	303

Proteins

Unit 1

MET 1 ASN 2 ILE 3 VAL 4 VAL 5 LEU 6 ILE 7 SER 8 GLY 9 ASN 10 GLY 11 SER 12 ASN 13 LEU 14 GLN 15 ALA 16 ILE 17 ILE 18 ASP 19 ALA 20 CYS 21 LYS 22 THR 23 ASN 24 LYS 25 ILE 26 LYS 27 GLY 28 THR 29 VAL 30 ARG 31 ALA 32 VAL 33 PHE 34 SER 35 ASN 36 LYS 37 ALA 38 ASP 39 ALA 40 PHE 41 GLY 42 LEU 43 GLU 44 ARG 45 ALA 46 ARG 47 GLN 48 ALA 49 GLY 50 ILE 51 ALA 52 THR 53 HIS 54 THR 55 LEU 56 ILE 57 ALA 58 SER 59 ALA 60 PHE 61 ASP 62 SER 63 ARG 64 GLU 65 ALA 66 TYR 67 ASP 68 ARG 69 GLU 70 LEU 71 ILE 72 HIS 73 GLU 74 ILE 75 ASP 76 MET 77 TYR 78 ALA 79 PRO 80 ASP 81 VAL 82 VAL 83 VAL 84 LEU 85 ALA 86 GLY 87 PHE 88 MET 89 ARG 90 ILE 91 LEU 92 SER 93 PRO 94 ALA 95 PHE 96 VAL 97 SER 98 HIS 99 TYR 100 ALA 101 GLY 102 ARG 103 LEU 104 LEU 105 ASN 106 ILE 107 HIS 108 PRO 109 SER 110 LEU 111 LEU 112 PRO 113 LYS 114 TYR 115 PRO 116 GLY 117 LEU 118 HIS 119 THR 120 HIS 121 ARG 122 GLN 123 ALA 124 LEU 125 GLU 126 ASN 127 GLY 128 ASP 129 GLU 130 GLU 131 HIS 132 GLY 133 THR 134 SER 135 VAL 136 HIS 137 PHE 138 VAL 139 THR 140 ASP 141 GLU 142 LEU 143 ASP 144 GLY 145 GLY 146 PRO 147 VAL 148 ILE 149 LEU 150 GLN 151 ALA 152 LYS 153 VAL 154 PRO 155 VAL 156 PHE 157 ALA 158 GLY 159 ASP 160 SER 161 GLU 162 ASP 163 ASP 164 ILE 165 THR 166 ALA 167 ARG 168 VAL 169 GLN 170 THR 171 GLN 172 GLU 173 HIS 174 ALA 175 ILE 176 TYR 177 PRO 178 LEU 179 VAL 180 ILE 181 SER 182 TRP 183 PHE 184 ALA 185 ASP 186 GLY 187 ARG 188 LEU 189 LYS 190 MET 191 HIS 192 GLU 193 ASN 194 ALA 195 ALA 196 TRP 197 LEU 198 ASP 199 GLY 200 GLN 201 ARG 202 LEU 203 PRO 204 PRO 205 GLN 206 GLY 207 TYR 208 ALA 209

Unit 2

MET 1 ASN 2 ILE 3 VAL 4 VAL 5 LEU 6 ILE 7 SER 8 GLY 9 ASN 10 GLY 11 SER 12 ASN 13 LEU 14 GLN 15 ALA 16 ILE 17 ILE 18 ASP 19 ALA 20 CYS 21 LYS 22 THR 23 ASN 24 LYS 25 ILE 26 LYS 27 GLY 28 THR 29 VAL 30 ARG 31 ALA 32 VAL 33 PHE 34 SER 35 ASN 36 LYS 37 ALA 38 ASP 39 ALA 40 PHE 41 GLY 42 LEU 43 GLU 44 ARG 45 ALA 46 ARG 47 GLN 48 ALA 49 GLY 50 ILE 51 ALA 52 THR 53 HIS 54 THR 55 LEU 56 ILE 57 ALA 58 SER 59 ALA 60 PHE 61 ASP 62 SER 63 ARG 64 GLU 65 ALA 66 TYR 67 ASP 68 ARG 69 GLU 70 LEU 71 ILE 72 HIS 73 GLU 74 ILE 75 ASP 76 MET 77 TYR 78 ALA 79 PRO 80 ASP 81 VAL 82 VAL 83 VAL 84 LEU 85 ALA 86 GLY 87 PHE 88 MET 89 ARG 90 ILE 91 LEU 92 SER 93 PRO 94 ALA 95 PHE 96 VAL 97 SER 98 HIS 99 TYR 100 ALA 101 GLY 102 ARG 103 LEU 104 LEU 105 ASN 106 ILE 107 HIS 108 PRO 109 SER 110 LEU 111 LEU 112 PRO 113 LYS 114 TYR 115 PRO 116 GLY 117 LEU 118 HIS 119 THR 120 HIS 121 ARG 122 GLN 123 ALA 124 LEU 125 GLU 126 ASN 127 GLY 128 ASP 129 GLU 130 GLU 131 HIS 132 GLY 133 THR 134 SER 135 VAL 136 HIS 137 PHE 138 VAL 139 THR 140 ASP 141 GLU 142 LEU 143 ASP 144 GLY 145 GLY 146 PRO 147 VAL 148 ILE 149 LEU 150 GLN 151 ALA 152 LYS 153 VAL 154 PRO 155 VAL 156 PHE 157 ALA 158 GLY 159 ASP 160 SER 161 GLU 162 ASP 163 ASP 164 ILE 165 THR 166 ALA 167 ARG 168 VAL 169 GLN 170 THR 171 GLN 172 GLU 173 HIS 174 ALA 175 ILE 176 TYR 177 PRO 178 LEU 179 VAL 180 ILE 181 SER 182 TRP 183 PHE 184 ALA 185 ASP 186 GLY 187 ARG 188 LEU 189 LYS 190 MET 191 HIS 192 GLU 193 ASN 194 ALA 195 ALA 196 TRP 197 LEU 198 ASP 199 GLY 200 GLN 201 ARG 202 LEU 203 PRO 204 PRO 205 GLN 206 GLY 207 TYR 208 ALA 209

Ligands

Unit 3	NHS 222 GAR 223
Unit 4	NHS 220 GAR 221